secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001104659-23-005586
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics increases change-in-control severance for CEO, CFO, and CTO
--------------------------------------------------------------------------------

- CEO Kevin Lee receives 24 months' base salary and benefits on change-of-control termination; subject to shareholder approval.
- CFO Lee Kalowski and CTO Michael Skynner get 18 months' base salary and benefits on change-of-control termination.
- Compensation committee approved amendments on Jan 17, 2023; CEO amendment pending AGM vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923005586/0001104659-23-005586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923005586/tm234142d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-005586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer